Table 2.
Disease-free survival events and number of deaths, comparison between low and high cNOTCH1 expression
Characteristic | cNOTCH1 expression | P value | |
---|---|---|---|
| |||
Low (n = 79) | High (n = 56) | ||
Disease-free survival eventsa | 58 | 47 | 0.207 |
Breast cancer events | 19 (24%) | 5 (9%) | 0.038 |
Lung metastasis | 15 (75%) | 5 (25%) | 0.141 |
Liver metastasis | 7 (9%) | 3 (5%) | 0.522 |
Bone metastasis | 12 (15%) | 2 (4%) | 0.042 |
Brain metastasis | 5 (6%) | 1 (2%) | 0.400 |
Regional lymph node recurrence | 7 (9%) | 1 (2%) | 0.139 |
Distant lymph node recurrence | 12 (15%) | 4 (7%) | 0.185 |
Local recurrence | 3 (4%) | 2 (4%) | > 0.999 |
Skin recurrence | 0 | 2 (4%) | 0.170 |
Adrenal gland metastasis | 2 (3%) | 0 | 0.511 |
Non-breast cancer deaths | 2 | 4 | 0.232 |
Cerebrovascular accident | 0 | 2 | 0.170 |
Heart failure | 1 | 0 | > 0.999 |
Rectal cancer | 1 | 0 | > 0.999 |
Endometrial cancer | 0 | 1 | 0.415 |
Hepatocellular carcinoma | 0 | 1 | 0.415 |
Breast cancer-related deaths | 8 | 5 | > 0.999 |
Abbreviations: cNOTCH1, Cytosolic NOTCH1 protein.
Excluding breast cancer-related and non-breast cancer-related events.